Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
Marieke PapePauline A J VissersDavid BertwistleLaura McDonaldLaurens V BeerepootMark Ivo van Berge HenegouwenSjoerd M LagardeStella MookNadia Haj MohammadPaul M JeeneHanneke W M van LaarhovenRob H A VerhoevenPublished in: The British journal of surgery (2022)
Disease recurred after curative treatment in 45.2 per cent of patients. Locoregional recurrence developed in only 18.8 per cent. The vast majority of patients presented with distant or combined locoregional and distant recurrence, and received best supportive care.